Skip to main content
OpenTrials

Clinical trial condition

Nasopharyngeal Neoplasms

Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

336 public trials 129 recruiting studies
Refine in advanced search Browse all conditions

Nasopharyngeal Neoplasms trial results

Recruiting

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

NCT07328854

Conditions
Carcinoma, Disease Attributes, Disease Progression, +16 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University cancer center Guangzhou, Guangdong, China
  • the Affiliated Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

NCT07328841

Conditions
Carcinoma, Disease Attributes, Disease Progression, +17 more
Locations
  • The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen University cancer center Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Sun Yat-sen University (SYSU) Guangzhou, Guangdong, China
View Trial Details
Recruiting

Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC

NCT07303023

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Eye, Ear, Nose and Throat Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
  • Sichuan Cancer Hospital & Institute Chengdu, China
View Trial Details
Recruiting

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

NCT07258979

Conditions
Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Zhangzhou Municiple Hospital of Fujian Province Zhangzhou, Fujian, China
View all 20 locations
View Trial Details
Recruiting

A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy

NCT06839066

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Recruiting

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

NCT05956587

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
View all 16 locations
View Trial Details

Related conditions